How Many People Are Actually Allergic to the Sun?

Roughly 10 to 20% of people in northern countries experience some form of sun allergy, making it far more common than most people realize. The most widespread type, called polymorphous light eruption (PMLE), affects up to 20 to 40% of fair-skinned women in northern Europe when they travel to sunny destinations. At the other end of the spectrum, rarer forms like solar urticaria account for less than 0.5% of all hives cases worldwide.

The term “sun allergy” covers several distinct conditions, each with different triggers, severity levels, and affected populations. Your likelihood of having one depends heavily on where you live, your skin type, your age, and even what medications you take.

The Most Common Type: Polymorphous Light Eruption

PMLE is by far the most prevalent sun allergy. It causes itchy red bumps, patches, or blisters on skin that’s been exposed to UV light, typically appearing hours after sun exposure and lasting several days. Many people call it “sun poisoning” or simply a sun rash.

Prevalence varies dramatically by geography. In Scandinavia, the United Kingdom, and the northern United States, PMLE rates are highest. In northern Europe, 20 to 40% of women who vacation in Mediterranean climates develop it. In Australia, where people get consistent year-round UV exposure, only 1 to 5% of the population is affected. This pattern, higher rates in northern latitudes, lower in southern ones, is one of the most consistent findings across studies. Altitude matters too, with higher elevations linked to more cases.

The condition is more common in women and typically starts in young adulthood. It tends to flare most aggressively in spring or early summer, when skin hasn’t been exposed to UV light for months. Many people with PMLE find their skin gradually “hardens” over the course of the summer, tolerating more sun as the weeks pass. This hardening effect is a real biological process: repeated UV exposure increases the density of certain immune cells in the skin that help suppress the overreaction.

Why the Immune System Reacts to Sunlight

In people without sun allergies, UV radiation triggers a mild suppression of the skin’s immune activity. This is a normal, protective response. In people with PMLE, that suppression fails. Instead, UV light damages skin cells, which release their contents into surrounding tissue. The immune system’s frontline cells pick up these altered proteins and treat them as threats, activating a cascade of inflammation.

Specifically, the skin’s sentinel immune cells don’t clear out of the upper skin layer the way they normally would after UV exposure. They stay put and begin recruiting other immune cells to the area. The result is a delayed allergic reaction, similar in mechanism to poison ivy or contact dermatitis, except the trigger is something your own body produced in response to sunlight. This is why PMLE symptoms typically appear hours after exposure rather than immediately.

Rarer Forms of Sun Allergy

Solar urticaria is a much less common condition where hives appear within minutes of sun exposure. It accounts for less than 0.5% of all urticaria cases and about 7% of all photodermatoses (the medical umbrella term for sun-triggered skin conditions). The hives typically develop within 5 to 15 minutes of exposure and fade within an hour or two of getting out of the sun. Unlike PMLE, which is delayed, solar urticaria is an immediate reaction, and in severe cases it can cause dizziness, nausea, or even anaphylaxis if large areas of skin are exposed at once.

Actinic prurigo is a chronic, intensely itchy sun allergy with a strong genetic component. It’s rare in most populations but significantly more common in certain Indigenous groups. An estimated 2% of Canadian Inuit people are affected. In Mexico, it’s concentrated in Indigenous and Mestizo populations living above 1,000 meters in altitude. Unlike PMLE, actinic prurigo often starts in childhood and can persist year-round rather than just in sunny months.

Chronic actinic dermatitis primarily affects older men. In a Scottish population study, about 1 in 2,000 people aged 75 and older had it. This condition causes persistent, eczema-like inflammation on sun-exposed skin, and unusually, it can be triggered not just by UV light but by visible light as well, making it particularly difficult to manage.

Medications That Create Sun Sensitivity

A significant number of sun reactions aren’t true allergies at all. They’re caused by medications that make the skin abnormally sensitive to UV light. Drug-induced photosensitivity accounts for about 7% of all diagnosed sun-related skin conditions and roughly 8% of all drug-related skin side effects.

The scale of potential exposure is striking. In Germany and Austria, researchers analyzing nationwide prescription databases found that about 49% of all dispensed medications contained drugs with known photosensitizing potential. That doesn’t mean half the population will develop a reaction, but it does mean a huge number of people are taking something that could make their skin more reactive to sunlight. Common culprits include certain antibiotics, anti-inflammatory painkillers, blood pressure medications, and some antidepressants.

If you’ve started a new medication and suddenly find your skin burning or breaking out faster than usual in the sun, the drug is a likely explanation. These reactions typically resolve when the medication is stopped or when you take adequate sun protection measures.

Who Is Most at Risk

Several factors increase the likelihood of developing a sun allergy:

  • Geography: Living in northern latitudes with long winters and limited UV exposure raises risk. The less consistent your sun exposure throughout the year, the more likely your skin is to overreact when it finally gets UV light.
  • Sex: Women are affected more often than men, particularly for PMLE.
  • Skin type: Fair-skinned individuals are more susceptible, though sun allergies occur across all skin types.
  • Age: PMLE tends to start in the 20s and 30s. Chronic actinic dermatitis skews toward people over 60.
  • Genetics: Actinic prurigo has a clear hereditary pattern in certain populations, and family history of PMLE increases your risk as well.

How Sun Allergies Are Diagnosed

Most mild cases of PMLE are diagnosed based on the pattern alone: itchy rash on sun-exposed skin in spring or early summer that clears up on its own within a week. No testing is needed.

For persistent, severe, or unusual reactions, dermatologists use a procedure called phototesting. Small areas of skin are exposed to controlled doses of UV light at specific wavelengths. The skin is then checked at multiple time points: immediately, 7 hours, 24 hours, and 48 hours after exposure. For solar urticaria, the reaction peaks within about 15 minutes. For PMLE and chronic actinic dermatitis, it may take a full day or two to appear. If medications are suspected, photopatch testing combines UV exposure with common drug allergens applied to the skin, with readings taken out to 96 hours.

Managing Sun Allergies

The hardening effect offers a practical strategy for many people with PMLE. Gradually increasing sun exposure in early spring, starting with short sessions, can train the skin’s immune response to tolerate UV light over the course of several weeks. Some dermatology clinics offer controlled UV light therapy in late winter to jumpstart this process before sunny weather arrives.

For day-to-day management, broad-spectrum sunscreen, protective clothing, and avoiding peak sun hours (typically 10 a.m. to 4 p.m.) are the foundation. People with solar urticaria or chronic actinic dermatitis often need more aggressive protection because their reactions can be triggered by a broader range of light wavelengths, including visible light that passes through regular sunscreen and window glass.

Topical steroid creams help manage flare-ups when they occur. For the small percentage of people with severe, treatment-resistant conditions like chronic actinic dermatitis, stronger immune-suppressing treatments may be necessary to control symptoms during high-exposure months.